Skip to main content

Table 4 Serious adverse events during the phase III study and 5-year follow-up observational study

From: Long-term observational study in Japanese hemodialysis patients who completed a 3-year clinical study of lanthanum carbonate

  Patients who continue LC Patients who did not continue LC
  Patients with events 2/30 (6.7 %) Patients with events 5/18 (27.8 %) Patients with events 3/12 (25.0 %)
  Number of patients Number of events Number of patients Number of events Number of patients Number of events
Infections and infestations
 Gangrene    1 1   
 Pneumonia      1a 1
 Pyelonephritis acute 1 1     
Neoplasms benign, malignant, and unspecified (including cysts and polyps)
 Colon cancer      1 1
Nervous system disorder
 Cerebral haemorrhage      1 1
Cardiac disorders
 Myocardial ischaemia    1 1   
 Tachycardia    1 1   
 Cardiac valve disease    1 1   
 Cardiac failure    1 1   
 Cardiac failure acute      1a 1
Vascular disorders
 Peripheral arterial occlusive disease    2 2 1 1
Gastrointestinal disorders
 Constipation 1 1     
 Upper gastrointestinal haemorrhage    1 1   
Surgical and medical procedures
 Foot amputation    1 1   
General disorders and administration site conditions
 Death    1a 1   
  1. aOutcome was death